Improvement of quality of life in third-line chemotherapy with lapatinib in a case of metastatic breast cancer

Tumori. 2013 May-Jun;99(3):e136-9. doi: 10.1177/030089161309900335.

Abstract

We describe a case of a 72-year-old patient suffering from metastatic breast cancer. The disease had progressed slowly and was almost asymptomatic for a significant time. Toxicity, following third-line treatment with lapatinib, was not significant, and side effects were well controlled. The case is an excellent example of a chronic neoplastic disease in a patient who could be defined as "long-surviving".

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Breast Neoplasms / pathology*
  • Breast Neoplasms / psychology*
  • Capecitabine
  • Cough / etiology
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / analogs & derivatives
  • Depression / etiology
  • Female
  • Fluorouracil / administration & dosage
  • Fluorouracil / analogs & derivatives
  • Humans
  • Lapatinib
  • Lung Neoplasms / complications
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / psychology
  • Lung Neoplasms / secondary*
  • Pain / etiology
  • Quality of Life*
  • Quinazolines / administration & dosage
  • Stress, Psychological / etiology
  • Treatment Outcome

Substances

  • Quinazolines
  • Lapatinib
  • Deoxycytidine
  • Capecitabine
  • Fluorouracil